A new monoclonal antibody that specifically recognises the MDR-3- encoded gene product

International Journal of Cancer

Volumn 80, Issue 2, 1999, Pages 265-271

  Larkin, Annemarie ^a   Moran, Elizabeth ^a   Alexander, Denis ^b   Doherty, Gerard ^a   Connolly, Lisa ^a   Kennedy, Susan M ^c   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE FLOW; CHOLESTASIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033579798     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19990118)80:2<265::aid-ijc16>3.0.co;2-%23     Document Type: Article

References (31)

1. ARAI, Y., MASUDA, M., SUGAWARA, I., ARAI, T., MOTOJI, T., TSURUO, T., OSHIMI, K. and MIZOGUCHI, H., Expression of the MDR-1 and MDR-3 gene products in acute and chronic leukemias. Leukemia Res., 21, 313-319 (1997).
2. BITTL, A., NAP, M., JAGER, W., LATHAN, B. and LANG, N., Immunohistochemical detection of Pgp in normal and malignant tissues: a comparative study of 3 monoclonal antibodies JSB-1, C219, 265/F4 against different epitopes using frozen and paraffin embedded tissue sections. Tumor Biol., 14, 155-166 (1993).
3. BUSCHMAN, E., ARCECI, R.J., CROOP, J.M., CHE, M., ARIAS, I.M. and HOUSMAN, D.E., Mdr-2 encodes a P-glycoprotein expressed in the bile canalicular membrane as determined by isoform specific antibodies. J. Biol. Chem., 267, 18093-18099 (1992).
4. CHIN, J.E., SOFFIR, R., NOONAN, K.E., CHOI, K. and RONINSON, I.B., Structure and expression of the human MDR (p-glycoprotein) gene family. Mol. cell. Biol., 9, 3808-3820 (1989).
5. CLYNES, M., REDMOND, A., MORAN, E. and GILVARRY, U., Multiple drug resistance in variants of a human non-small cell lung carcinoma cell line, DLKPA. Cytotechnology, 10, 75-89 (1992).
6. CROOP, J.M., P-glycoprotein structure and evolutionary homologies. Cytotechnology, 12, 1-32 (1993).
7. CROOP, J.M., RAYMOND, M., HABER, D., DEVAULT, A., ACRECI, R.J., GROS, P. and HOUSMAN, D.E., The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. cell. Biol., 9, 1346-1350 (1989).
8. DE VREE, J.M., JACQUEMIN, E., STURM, E., CRESTEIL, D., BOSMA, P.J., ATEN, J., DELEUZE, J.F., DESROCHERS, M., BURDELSKI, M., BERNARD, O., OUDE ELFERINK, R.P. and HADCHOUEL, M., Mutations in the MDR-3 gene cause progressive familial intrahepatic choleostasis. Proc. nat. Acad. Sci. (Wash.), 95, 282-287 (1998).
9. HEENAN, M., O'DRISCOLL, L., CLEARY, I., CONNOLLY, L. and CLYNES, M., Isolation from a human MDR cell line of multiple clonal subpopulations which exhibit significantly different drug resistance. Int. J. Cancer, 71, 907-915 (1997).
10. HERWEIJER, H., SONNEVELD, P., BAAS, F. and NOOTER, K., Expression of MDR-1 and MDR-3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J. nat. Cancer Inst., 82, 1133-1140 (1990).
11. KINO, K., TAGUCHI, Y., YAMADA, K., KOMANO, T. and UEDA, K., Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR-1 and MDR-2/ P-glycoproteins. FEBS Lett., 399, 29-32 (1996).
12. KOHLER, G. and MILSTEIN, C., Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (Lond.), 256, 495-497 (1975).
13. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
14. LAW, E., GILVARRY, U., LYNCH, V., GREGORY, B., GRANT, G. and CLYNES, M., Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines. Cancer Genet. Cytogenet., 59, 111-118 (1992).
15. LUDESCHER, C., HILBE, W., EISTERER, W., PREUSS, E., HUBER, C., GOTWALD, M., HOEMANN, J. and THALER, J., Activity of P-glycoprotein in B-cell chronic lymphocytic leukaemia determined by a flow cytometric assay. J. nat. Cancer. Inst., 85, 1751-1758 (1993).
16. MARIE, J.P., ZHOU D.C., GURBUXANI, S., LEGRAND, O. and ZITTOUN, R., Mdr-1/ p-glycoprotein in haematological neoplasms. Europ. J. Cancer, 32A, 1034-1038 (1996).
17. MORAN, E., LARKIN, A.M., DOHERTY, G., KELEHAN, P., KENNEDY, S.M. and CLYNES, M., A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections. J. clin. Pathol., 50, 465-471 (1997).
18. NOOTER, K. and SONNEVELD, P., Multidrug resistance (MDR) genes in haematological malignancies. Cytotechnology, 12, 213-230 (1993).
19. NOOTER, K., SONNEVELD, P., JANSSEN, A., OOSTRUM, R., BOERSMA, T., HERWEIJER, H., VALERIO, D., HAGEMEIJER, A. and BAAS, F., Expression of the MDR-3 gene in prolymphocytic leukemia: association with cyclosporin-A induced increase in drug accumulation. Int. J. Cancer, 45, 626-631(1990).
20. O'DRISCOLL, L., Investigation of mechanisms of MDR using PCR. PhD Thesis, Dublin City University (1994).
21. SCHINKEL, A.H., SMIT, J.J., VAN TELLINGEN, O., BEIJNEN, J.H., WAGENAAR, E., VAN DEEMTER, L., MOL, C.A., VAN DER VALK, M.A., ROBANUS-MAANDAG, E.C., TE RIELE, H.P.I., BERNS, A.J.M. and BORST, P., Disruption of the mouse mdr1a P-glycoprotein gene leads to deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 77, 491-502 (1994).
22. SMIT, J.J., BAAS, F., HOOGENDIJK, J.E., JANSEN, G.H., VAN DER VALK, M.A., SCHINKEL, A.H., BERNS, A.J., ACTON, D., NOOTER, K., BURGER, H., SMITH, S.J. and BORST, P., Peripheral neuropathy in mice transgenic for a human MDR-3 P-glycoprotein mini-gene. J. Neurosci., 16, 6386-6393 (1996).
23. SMIT, J.J., SCHINKEL, A.H., MOL, C.A., MAJOOR, D., MOOI, W.J., JONGSMA, A., LINKE, C.R. and BORST, P., Tissue distribution of the human P-glycoprotein. Lab. Invest., 71, 638-649 (1994).
24. SMIT, J.J. and 12 OTHERS, Homogenous disruption of the murine mdr-2 P-glycoprotein gene leads to a complete absence of phosolipid from bile and to liver disease. Cell. 75, 451-462 (1993).
25. SMITH, A.J., The substrate specificities of the human MDR-1 and MDR-3 P-glycoproteins. University of Amsterdam, PhD Thesis (1998).
26. SMITH, A.J., TIMMERMANS-HEREIJGERS, J.L.P.M., ROELOFSEN, B., WIRTZ, K.W.A., VAN BLITTERSWIJK, W.J., SMIT, J.J., SCHINKEL, A.H. and BORST, P., The human MDR-3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett., 354, 263-266 (1994).
27. SONNEVELD, P., NOOTER, K., BURGHOUTS, J.T.M., HERWEIJER, H., ADRIAANSEN, H.J. and VAN DONGEN, J.J.M., High expression of the MDR-3 multiple resistance gene in advanced stage chronic lymphocytic leukemia. Blood, 79, 1496-1500 (1992).
28. TOWBIN, H., STAEHELIN, T. and GORDON, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. nat. Acad. Sci. (Wash.), 76a, 4350-4354 (1979).
29. VAN DER BLIEK, A.M., KOOIMAN, P.M., SCHNEIDER, C. and BORST, P., Sequence of MDR-3 cDNA encoding a human P-glycoprotein. Gene, 71, 401-411 (1988).
30. VAN HELVOORT, A., SMITH, A.J., SPRONG, H., FRITZSCHE, I., SCHINKEL, A.H., BORST, P. and VAN MEER, G., MDR-1 P-glycoprotein is a lipid translocase of broad specificity, while MDR-3 P-glycoprotein specifically translocates phosphatidylcholine. Cell, 87, 507-517 (1996).
31. ZHANG, F., RILEY, J. and GANT, T.W., Intrinsic multidrug class 1 and 2 gene expression and localisation in rat and human mammary tumours. Lab. Invest., 75, 413-426 (1996).